Patient Characteristics at Baseline
| Characteristic | Data |
| Age (y) | |
| Median | 73 |
| Range | 43–87 |
| PSA (ng/dL) | |
| Median | 342 |
| Range | 5–5,910 |
| Hemoglobin (g/L) | |
| Median | 10.6 |
| Range | 6–15 |
| WBCs (×103/dL) | |
| Median | 4.9 |
| Range | 3.3–12.4 |
| Platelets (×103/dL) | |
| Median | 251 |
| Range | 62–557 |
| Creatinine (mg/dL) | |
| Median | 0.86 |
| Range | 0.3–1.4 |
| Alkaline phosphatase (U/L) | |
| Median | 179 |
| Range | 38–1,607 |
| Sites of metastasis (n) | |
| Bone | 81 (99) |
| Lymph node | 65 (79) |
| Liver | 17 (21) |
| Lung | 9 (11) |
| Brain | 1 (1) |
| Prior therapy (n) | |
| Prostatectomy | 45 (55) |
| RTx to prostate region | 38 (46) |
| Hormones | 81 (99) |
| Docetaxel | 52 (63) |
| Cabazitaxel | 11 (13) |
| Abiraterone | 69 (84) |
| Enzalutamide | 66 (80) |
| 223Ra | 19 (23) |
| RTx to bone | 31 (38) |
WBCs = white blood cells; RTx = radiation therapy.